Page 153 - Read Online

Page 304 Balasubramaniam et al. J Transl Genet Genom 2020;4:285-306 I http://dx.doi.org/10.20517/jtgg.2020.34

NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 2001;68:1344-52.
90. Bindu PS, Sonam K, Chiplunkar S. Mitochondrial leukoencephalopathies: a border zone between acquired and inherited white matter
disorders in children? Mult Scler Relat Disord 2018;20:84-92.
91. Björkman K, Sofou K, Darin N, Holme E, GKollberg G, et al. Broad phenotypic variability in patients with complex I deficiency due to
mutations in NDUFS1 and NDUFV1. Mitochondrion 2015;21:33-40.
92. Breningstall GN, Shoffner J, Patterson RJ. Siblings with leukoencephalopathy. Semin Pediatr Neurol 2008;15:212-5.
93. Bugiani M, Invernizzi F, Alberio S, Briem E, Lamantea E, et al. Clinical and molecular findings in children with complex I deficiency.
Biochim Biophys Acta 2004;1659:136-47.
94. Dinwiddie DL, Smith LD, Miller NA, Atherton AM, Farrow EG, et al. Diagnosis of mitochondrial disorders by concomitant next-
generation sequencing of the exome and mitochondrial genome. Genomics 2013;102:148-56.
95. Incecik F, Herguner OM, Besen S. Late-onset leigh syndrome due to NDUFV1 mutation in a 10-year-old boy initially presenting with
ataxia. J Pediatr Neurosci 2018;13:205-7.
96. Koene S, Rodenburg RJ, Van der Knaap MS, Willemsen MAAP, Sperl W, et al. Natural disease course and genotype-phenotype
correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis 2012;35:737-47.
97. Lal D, Becker K, Motameny S, Altmüller J, Thiele H, et al. Homozygous missense mutation of NDUFV1 as the cause of infantile
bilateral striatal necrosis. Neurogenetics 2013;14:85-7.
98. Laugel V, This-Bernd V, Cormier-Daire V, Speeg-Schatz C, de Saint-Martin A, et al. Early-onset ophthalmoplegia in Leigh-like syndrome
due to NDUFV1 mutations. Pediatr Neurol 2007;36:54-7.
99. Lee JS, Yoo T, Lee M, Lee Y, Jeon E, et al. Genetic heterogeneity in Leigh syndrome: Highlighting treatable and novel genetic causes.
Clin Genet 2020;97:586-94.
100. Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S, et al. Targeted exome sequencing of suspected mitochondrial disorders. Neurology
2013;80:1762-70.
101. Marin SE, Mesterman R, Robinson B, Rodenburg RJ, Smeitink J, et al. Leigh syndrome associated with mitochondrial complex I
deficiency due to novel mutations In NDUFV1 and NDUFS2. Gene 2013;516:162-7.
102. Moran M, Rivera H, Sanchez-Arago M, Blázquez A, Merinero B, et al. Mitochondrial bioenergetics and dynamics interplay in complex
I-deficient fibroblasts. Biochim Biophys Acta 2010;1802:443-53.
103. Nafisinia M, Guo Y, Dang X, Li J, Chen Y, et al. Whole exome sequencing identifies the genetic basis of late-onset leigh syndrome in a
patient with MRI but little biochemical evidence of a mitochondrial disorder. JIMD Rep 2017;32:117-24.
104. Ortega-Recalde O, Fonseca DJ, Patino LC, Atuesta JJ, Rivera-Nieto C, et al. A novel familial case of diffuse leukodystrophy related to
NDUFV1 compound heterozygous mutations. Mitochondrion 2013;13:749-54.
105. Pronicka E, Piekutowska-Abramczuk D, Ciara E, Trubicka J, Rokicki D, et al. New perspective in diagnostics of mitochondrial disorders:
two years’ experience with whole-exome sequencing at a national paediatric centre. J Transl Me 2016;14:174.
106. Rubio-Gozalbo ME, Ruitenbeek W, Wendel U, Sengers RC, Trijbels JM, et al. Systemic infantile complex I deficiency with fatal outcome
in two brothers. Neuropediatrics 1998;29:43-5.
107. Vilain C, Rens C, Abey A, Balériaux D, Van Bogaert P, et al. A novel NDUFV1 gene mutation in complex I deficiency in consanguineous
siblings with brainstem lesions and Leigh syndrome. Clin Genet 2012;82:264-70.
108. Zafeiriou DI, Rodenburg RJ, Scheffer H, van den Heuvel LP, Pouwels PJW, et al. MR spectroscopy and serial magnetic resonance
imaging in a patient with mitochondrial cystic leukoencephalopathy due to complex I deficiency and NDUFV1 mutations and mild
clinical course. Neuropediatrics 2008;39:172-5.
109. Zhang J, Liu M, Zhang Z, Zhou L, Kong W, et al. Genotypic spectrum and natural history of cavitating leukoencephalopathies in
childhood. Pediatr Neurol 2019;94:38-47.
110. Loeffen JL, Smeitink JS, Trijbels JM, Janssen AJ, Triepels RH, et al. Isolated complex I deficiency in children: clinical, biochemical, and
genetic aspects. Hum Mutat 2000;15:123-34.
111. Bénit P, Chretien D, Kadhom N, Giurgea I, De Lonlay-Debeney P, et al. Mutant NDUFV2 subunit of mitochondrial complex I causes
early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat 2003;21:582-6.
112. Pagniez-Mammeri H, Lombes A, Brivet M, Ogier-de Baulny H, Landrieu P, et al. Rapid screening for nuclear genes mutations in isolated
respiratory chain complex I defects. Mol Genet Metab 2009;96:196-200.
113. Cameron JM, Mackay N, Feigenbaum A, Tarnopolsky M, Blaseret S, et al. Exome sequencing identifies complex I NDUFV2 mutations
as a novel cause of Leigh syndrome. Eur J Paediatr Neurol 2015;19:525-32.
114. Liu HY, Liao PC, Chuang KT, Kao MC. Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2)
and its association with early-onset hypertrophic cardiomyopathy and encephalopathy. J Biomed Sci 2011;18:29.
115. Aldera AP, Govender D. Gene of the month: SDH. J Clin Pathol 2018;7:95-7.
116. Evenepoel L, Papathomas TG, Krol N, Korpershoek E, de Krijger RR, et al. Toward an improved definition of the genetic and tumor
spectrum associated with SDH germ-line mutations. Genet Med 2015;17:610-20.
117. Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, et al. Clinical characterization of the pheochromocytoma and paraganglioma
susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention. JAMA Oncol 2017;3:1204-12.
118. Burnichon N, Briere JJ, Libe R, Vescovo L, Rivière J, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet
2010;19:3011-20.
119. Dwight T, Mann K, Benn DE, Robinson BG, McKelvie P, et al. Familial SDHA mutation associated with pituitary adenoma and
pheochromocytoma/paraganglioma. J Clin Endocrinol Metab 2013;98:E1103-8.